1. Nanoparticle-mediated therapeutic compounds delivery to glioblastoma
   L. Gallego et al, 2020, Expert Opinion on Drug Delivery CrossRef
2. Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
   Sathishbabu Paranthaman et al, 2020, Pharmaceutics CrossRef
3. 6-Cinnamoyl-4-arylaminothienopyrimidines as highly potent cytotoxic agents: Design, synthesis and structure-activity relationship studies
   Mahsa Toolabi et al, 2020, European Journal of Medicinal Chemistry CrossRef
4. Understanding the role of endothelial cells in brain tumor formation and metastasis: a proposition to be explored for better therapy
   Tejas Girish Agnihotri et al, 2023, Journal of the National Cancer Center CrossRef
5. Recent Advancements and Strategies for Overcoming the Blood–Brain Barrier Using Albumin-Based Drug Delivery Systems to Treat Brain Cancer, with a Focus on Glioblastoma
   Camelia-Elena Tincu (Iurciuc) et al, 2023, Polymers CrossRef
6. Targeted sonodynamic destruction of glioblastoma cells using antibody–titanium dioxide nanoparticle conjugates
   George P Lee et al, 2021, Nanomedicine CrossRef
7. Macromolecular Drug Carriers for Targeted Glioblastoma Therapy: Preclinical Studies, Challenges, and Future Perspectives
   Drazen Raucher et al, 2018, Frontiers in Oncology CrossRef
8. Preliminary in vitro comparison of 111In and 131I labeled nimotuzumabs
   Zhonghui Liao et al, 2021, Journal of Radioanalytical and Nuclear Chemistry CrossRef
9. Does conjugation strategy matter? Cetuximab-conjugated gold nanocages for targeting triple-negative breast cancer cells
   S. Avvakumova et al, 2019, Nanoscale Advances CrossRef
10. Enhancement of nanoparticle-mediated double suicide gene expression driven by ‘E9-hTERT promoter’ switch in dedifferentiated thyroid cancer cells
    Aoshuang Chang et al, 2021, Bioengineered CrossRef
11. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis
    Mengyuan Zhang et al, 2022, PeerJ CrossRef